Presentation on Lympro July 31st 2014
Quotes from the presenter.
' very nervous when I get nearly two digit cohorts."
"small underpowered studies"
The statistical sig was expected, the key is will they be able to use it in real life.
He goes over how to select the sen and spec. That is important.
In other words, you get to pick the range of sen and spec as noted in the chart.
sen of 70 at spec of 82.4 OR sen of 80 at spec 70%
THE SAME NUMBERS THEY GOT ON POSTER THREE ESSENTIALLY.
NOW that does not mean that the test is useless. The concept is VERY important for finding the CAUSE and treatment of AD, and very possibly the p16 that was mentioned will do that.
Basically this test is as good as the OPKO test. That test is on the market from Lab Corp and measures antibodies. EVEN IF the numbers were good, there would have been NO CNN coverage because of the TINY numbers.
In other words, LOOK OUT BELOW to the pps. And for those who listened to me and not GC when he tried to OBFUSCATE THE NUMBERS from Poster three. Thanks for listening.